Search projects
193 projects found
NeuroDeRisk
f308e53e-5f11-11eb-917b-acde48001122
Neurotoxicity de-risking in preclinical drug discovery
Keywords: IMI projects Tools for predicting/monitoring safety 3Rs - animal use in research
MiBiPa - Non-invasive microbiome-derived multi-omic biomarker...
ELU-1-913FE2-1
Parkinson’s disease (PD) research benefits from knowledge of disease-specific risk and resilience factors and elucidation of pathophysiological concepts on the emergence of neurodegeneration. Presently the propagation of a-synuclein aggregation in PD is proposed to start in the periphery, i.e. in the enteric nervous system and the olfactory bulb. Aberrations within the gastrointestinal and nasal microbiomes may play a role in the initiation of this process. This is of particular relevance in...
Keywords: Parkinson’s disease microbiome biomarker
ORBITO
f3f10c06-5f11-11eb-917b-acde48001122
Oral biopharmaceutics tools
Keywords: IMI projects Tools for predicting/monitoring safety Drug delivery
OncoTrack
dc9c45f2-147a-11eb-b51f-8c8590c45a21
Methods for systematic next generation oncology biomarker development
Keywords: IMI projects Translational Medicine Cancer Tools for predicting/monitoring safety
Open PHACTS
f31a26c8-5f11-11eb-917b-acde48001122
The Open Pharmacological Concepts Triple Store
Keywords: IMI projects Big data and knowledge management Drug discovery
optima - Optima
9d2aca6a-ac64-4c38-a86c-8ef971f1288f
Optimal treatment for patients with solid tumours in Europe through artificial intelligence
Keywords: IMI projects IMI2 Cancer Real-world data Evidence Artificial intelligence
PARADIGM
f2435ddc-5f11-11eb-917b-acde48001122
Patients active in research and dialogues for an improved generation of medicines: advancing meaningful patient engagement in the life cycle of medicines for better health outcomes
Keywords: IMI projects Clinical trial design Patient involvement in R&D Regulatory and HTA processes
PD-MIND
efe67006-5f11-11eb-917b-acde48001122
Parkinson disease with mild cognition impairment treated with nicotinic agonist drug
Keywords: IMI projects Neurodegenerative diseases Conducting clinical trials